RBC’s $22 price target implies an upside of 74% for shares of Biohaven.
Netflix’s fourth-quarter results left the Street disappointed. Where analysts see the stock going
While analysts maintained their long-term bullish stance on Netflix, many also cut their price targets for the streamer.
Wednesday’s big stock stories: What’s likely to move the market in the next trading session
Stocks sold off on Tuesday as President Trump stepped up his rhetoric around Greenland and tariffs. The three major averages saw their worst day since October.
Deutsche Bank says the ‘honeymoon is over’ for AI
Artificial intelligence will undergo periods of disillusionment, dislocation and increasing distrust in 2026, the firm said.
The ‘trap doors’ to watch in the S&P 500 and Nasdaq as trade pressure mounts, according to the charts
Todd Gordon reveals the levels he’s watching in the market and how to hedge against a prolonged decline.
Where investors can find some reliable income as most U.S. assets see big selling pressure
Investors can turn to bonds and dividend stocks for income as they ride out the market volatility, experts said.
Danish pension fund to sell $100 million in Treasuries, citing ‘poor’ U.S. government finances
AkademikerPension’s move comes amid increasing tensions with the U.S. over Greenland.
These safe stocks could ride out any extended market sell-off
As U.S. markets take a big hit with the chance of more turmoil ahead, certain stocks could be a bastion of safety for investors given their low volatility.
How pro traders are playing defense against this selloff, according to JPMorgan strategists
JPMorgan strategists said it is prudent to maintain near-term hedges even as their broader outlook on equities remains constructive.
One of the best trades of 2025 has stalled out. Josh Brown on the utilities buying opportunity
Josh Brown and Sean Russo walk CNBC Pro readers through the utilities sector and what’s next for some names on their Best Stocks list.